Aldeyra Therapeutics, Inc.

ALDX · Nasdaq · SIC 2834: Pharmaceutical Preparations
264
SEC Filings

Business Summary

5 Item 1A. Risk Factors 31 Item 1B. Unresolved Staff Comments 87 Item 1C. Cybersecurity 87 Item 2. Properties 87 Item 3. Legal Proceedings 88 Item 4. Mine Safety Disclosures 88 Part II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 89 Item 6. [Reserved] 89 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 90 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 100 Item 8...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionALDXdiscussed_in_filing Cybersecurity
topic_mentionALDXdiscussed_in_filing Cybersecurity
topic_mentionALDXdiscussed_in_filing Cybersecurity
topic_mentionALDXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-272025-12-310001193125-26-083012EDGAR87K words
2025-02-282024-12-310000950170-25-030102EDGAR—
2024-03-072023-12-310000950170-24-027933EDGAR—
2023-03-092022-12-310000950170-23-006998EDGAR—
2022-03-172021-12-310000950170-22-004111EDGAR—
2021-03-112020-12-310001564590-21-012501EDGAR—
2020-03-122019-12-310001564590-20-010493EDGAR—
2019-03-082018-12-310001564590-19-006997EDGAR—
2018-03-292017-12-310001193125-18-102077EDGAR—
2017-03-302016-12-310001193125-17-104228EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266989EDGAR59K words
2025-08-072025-06-300000950170-25-104971EDGAR—
2025-05-142025-03-310000950170-25-071602EDGAR—
2024-11-072024-09-300000950170-24-123248EDGAR—
2024-08-012024-06-300000950170-24-089238EDGAR—
2024-05-022024-03-310000950170-24-052056EDGAR—
2023-11-032023-09-300000950170-23-058829EDGAR—
2023-08-032023-06-300000950170-23-037934EDGAR—
2023-05-042023-03-310000950170-23-017827EDGAR—
2022-11-102022-09-300000950170-22-024434EDGAR—
2022-08-052022-06-300000950170-22-015115EDGAR—
2022-05-052022-03-310000950170-22-007890EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001193125-26-137984EDGAR1K words
2026-03-170001193125-26-109511EDGAR—
2025-12-310001193125-25-338394EDGAR—
2025-12-160001193125-25-319638EDGAR—
2025-11-130001193125-25-278804EDGAR—
2025-10-280001193125-25-252200EDGAR—
2025-08-190000950170-25-109932EDGAR—
2025-07-170001213900-25-064869EDGAR—
2025-06-260001213900-25-058035EDGAR—
2025-06-170001213900-25-054949EDGAR—

264 total filings indexed. 232 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001341235
TickerALDX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 462ddc89c3d90686f3407861ba8ff96c37699f02a1739295dc0d7516a869231b
parent: 94f48d296abe15b207c5c39f48d3c5faee40bd9ae1c09bc0aaa6eb252d494db8
content hash: 9796d0dbfc6bc2460c9966bef7663e56e2a61faa96eee0e2e6b114b0cad7d92e
signed: 2026-04-13T04:43:34.845Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf